| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | IgG receptor activity | 8.07e-07 | 7 | 58 | 3 | GO:0019770 | |
| GeneOntologyMolecularFunction | IgG binding | 3.77e-06 | 11 | 58 | 3 | GO:0019864 | |
| GeneOntologyMolecularFunction | immune receptor activity | 8.24e-06 | 165 | 58 | 6 | GO:0140375 | |
| GeneOntologyMolecularFunction | immunoglobulin receptor activity | 8.28e-06 | 14 | 58 | 3 | GO:0019763 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | FCGR2C ADGRG3 KLRF1 DRD3 CSF1R HMCN2 FCGR2A FCGR2B IL21R ADGRE4P TAS1R2 TNFRSF10A CR1 PLXNA1 | 2.42e-05 | 1353 | 58 | 14 | GO:0004888 |
| GeneOntologyMolecularFunction | low-affinity IgG receptor activity | 4.96e-05 | 4 | 58 | 2 | GO:0019772 | |
| GeneOntologyMolecularFunction | immunoglobulin binding | 1.55e-04 | 36 | 58 | 3 | GO:0019865 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 7.32e-04 | 140 | 58 | 4 | GO:0001221 | |
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 7.38e-04 | 14 | 58 | 2 | GO:0005130 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | 9.24e-04 | 149 | 58 | 4 | GO:1990782 | |
| GeneOntologyMolecularFunction | transcription factor binding | 1.42e-03 | 753 | 58 | 8 | GO:0008134 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 2.02e-03 | 23 | 58 | 2 | GO:0034235 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 2.17e-03 | 188 | 58 | 4 | GO:0005201 | |
| GeneOntologyMolecularFunction | opsonin binding | 2.38e-03 | 25 | 58 | 2 | GO:0001846 | |
| GeneOntologyMolecularFunction | filamin binding | 3.20e-03 | 29 | 58 | 2 | GO:0031005 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 3.20e-03 | 29 | 58 | 2 | GO:0035325 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated immunity | 2.89e-07 | 96 | 58 | 6 | GO:0002704 | |
| GeneOntologyBiologicalProcess | negative regulation of cytokine production | CD84 CEACAM5 ANGPT1 FN1 FCGR2A FCGR2B UBR5 SIGLEC1 CR1 CEACAM1 | 4.00e-07 | 444 | 58 | 10 | GO:0001818 |
| GeneOntologyBiologicalProcess | negative regulation of immune effector process | 4.10e-07 | 166 | 58 | 7 | GO:0002698 | |
| GeneOntologyBiologicalProcess | MAPK cascade | CD84 DACT1 DRD3 SETX CEACAM5 ANGPT1 CSF1R FN1 FCGR2A FCGR2B TNFRSF10A MAP3K7 CEACAM1 | 1.40e-06 | 930 | 58 | 13 | GO:0000165 |
| GeneOntologyBiologicalProcess | immune complex clearance | 1.75e-06 | 9 | 58 | 3 | GO:0002434 | |
| GeneOntologyBiologicalProcess | regulation of MAPK cascade | CD84 DACT1 DRD3 CEACAM5 ANGPT1 CSF1R FN1 FCGR2A FCGR2B TNFRSF10A MAP3K7 CEACAM1 | 2.23e-06 | 815 | 58 | 12 | GO:0043408 |
| GeneOntologyBiologicalProcess | cell junction organization | CNTN4 DACT1 CEACAM5 CSF1R HMCN2 FN1 FCGR2A FCGR2B PCLO MDGA2 IGSF11 CEACAM1 TBX5 | 2.34e-06 | 974 | 58 | 13 | GO:0034330 |
| GeneOntologyBiologicalProcess | regulation of cytokine production | CD84 FCGR2C CEACAM5 ANGPT1 CSF1R FN1 FCGR2A FCGR2B UBR5 SIGLEC1 CR1 MAP3K7 CEACAM1 | 3.48e-06 | 1010 | 58 | 13 | GO:0001817 |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte mediated immunity | 3.62e-06 | 83 | 58 | 5 | GO:0002707 | |
| GeneOntologyBiologicalProcess | negative regulation of humoral immune response mediated by circulating immunoglobulin | 4.56e-06 | 12 | 58 | 3 | GO:0002924 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte activation | 4.80e-06 | 240 | 58 | 7 | GO:0002695 | |
| GeneOntologyBiologicalProcess | antibody-dependent cellular cytotoxicity | 5.92e-06 | 13 | 58 | 3 | GO:0001788 | |
| GeneOntologyBiologicalProcess | negative regulation of type I hypersensitivity | 7.77e-06 | 2 | 58 | 2 | GO:0001811 | |
| GeneOntologyBiologicalProcess | cytokine production | CD84 FCGR2C CEACAM5 ANGPT1 CSF1R FN1 FCGR2A FCGR2B UBR5 SIGLEC1 CR1 MAP3K7 CEACAM1 | 8.06e-06 | 1091 | 58 | 13 | GO:0001816 |
| GeneOntologyBiologicalProcess | negative regulation of cell activation | 8.95e-06 | 264 | 58 | 7 | GO:0050866 | |
| GeneOntologyBiologicalProcess | type IIa hypersensitivity | 9.37e-06 | 15 | 58 | 3 | GO:0001794 | |
| GeneOntologyBiologicalProcess | type II hypersensitivity | 9.37e-06 | 15 | 58 | 3 | GO:0002445 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol 3-kinase/protein kinase B signal transduction | 1.10e-05 | 382 | 58 | 8 | GO:0043491 | |
| GeneOntologyBiologicalProcess | negative regulation of B cell mediated immunity | 1.15e-05 | 16 | 58 | 3 | GO:0002713 | |
| GeneOntologyBiologicalProcess | negative regulation of immunoglobulin mediated immune response | 1.15e-05 | 16 | 58 | 3 | GO:0002890 | |
| GeneOntologyBiologicalProcess | negative regulation of apoptotic process | DRD3 SETX CEACAM5 ANGPT1 CSF1R FN1 FCGR2A FCGR2B BAG4 DAPK1 MDGA2 TNFRSF10A MAP3K7 | 1.21e-05 | 1133 | 58 | 13 | GO:0043066 |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 1.38e-05 | 52 | 58 | 4 | GO:0031342 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte degranulation | 1.40e-05 | 17 | 58 | 3 | GO:0043301 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 1.40e-05 | 187 | 58 | 6 | GO:0007156 | |
| GeneOntologyBiologicalProcess | negative regulation of programmed cell death | DRD3 SETX CEACAM5 ANGPT1 CSF1R FN1 FCGR2A FCGR2B BAG4 DAPK1 MDGA2 TNFRSF10A MAP3K7 | 1.72e-05 | 1171 | 58 | 13 | GO:0043069 |
| GeneOntologyBiologicalProcess | negative regulation of production of molecular mediator of immune response | 1.85e-05 | 56 | 58 | 4 | GO:0002701 | |
| GeneOntologyBiologicalProcess | negative regulation of humoral immune response | 1.98e-05 | 19 | 58 | 3 | GO:0002921 | |
| GeneOntologyBiologicalProcess | negative regulation of immunoglobulin production | 2.33e-05 | 20 | 58 | 3 | GO:0002638 | |
| GeneOntologyBiologicalProcess | negative regulation of cytotoxic T cell degranulation | 2.33e-05 | 3 | 58 | 2 | GO:0043318 | |
| GeneOntologyBiologicalProcess | regulation of cytotoxic T cell degranulation | 2.33e-05 | 3 | 58 | 2 | GO:0043317 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated immunity | 2.47e-05 | 309 | 58 | 7 | GO:0002703 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte proliferation | 2.57e-05 | 124 | 58 | 5 | GO:0050672 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 2.68e-05 | 313 | 58 | 7 | GO:0098742 | |
| GeneOntologyBiologicalProcess | negative regulation of mononuclear cell proliferation | 2.78e-05 | 126 | 58 | 5 | GO:0032945 | |
| GeneOntologyBiologicalProcess | Fc receptor signaling pathway | 2.78e-05 | 62 | 58 | 4 | GO:0038093 | |
| GeneOntologyBiologicalProcess | positive regulation of MAPK cascade | 2.85e-05 | 571 | 58 | 9 | GO:0043410 | |
| GeneOntologyBiologicalProcess | leukocyte mediated immunity | 3.05e-05 | 576 | 58 | 9 | GO:0002443 | |
| GeneOntologyBiologicalProcess | regulation of humoral immune response mediated by circulating immunoglobulin | 3.13e-05 | 22 | 58 | 3 | GO:0002923 | |
| GeneOntologyBiologicalProcess | lymphocyte mediated immunity | 3.50e-05 | 449 | 58 | 8 | GO:0002449 | |
| GeneOntologyBiologicalProcess | negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 3.56e-05 | 66 | 58 | 4 | GO:0002823 | |
| GeneOntologyBiologicalProcess | positive regulation of tumor necrosis factor production | 3.60e-05 | 133 | 58 | 5 | GO:0032760 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte proliferation | 3.73e-05 | 134 | 58 | 5 | GO:0070664 | |
| GeneOntologyBiologicalProcess | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 4.06e-05 | 334 | 58 | 7 | GO:0051896 | |
| GeneOntologyBiologicalProcess | positive regulation of tumor necrosis factor superfamily cytokine production | 4.15e-05 | 137 | 58 | 5 | GO:1903557 | |
| GeneOntologyBiologicalProcess | receptor-mediated endocytosis | 4.29e-05 | 337 | 58 | 7 | GO:0006898 | |
| GeneOntologyBiologicalProcess | regulation of tumor necrosis factor production | 4.49e-05 | 230 | 58 | 6 | GO:0032680 | |
| GeneOntologyBiologicalProcess | hypersensitivity | 4.64e-05 | 25 | 58 | 3 | GO:0002524 | |
| GeneOntologyBiologicalProcess | negative regulation of hypersensitivity | 4.65e-05 | 4 | 58 | 2 | GO:0002884 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte mediated immunity | 4.71e-05 | 232 | 58 | 6 | GO:0002706 | |
| GeneOntologyBiologicalProcess | negative regulation of adaptive immune response | 4.75e-05 | 71 | 58 | 4 | GO:0002820 | |
| GeneOntologyBiologicalProcess | regulation of tumor necrosis factor superfamily cytokine production | 5.18e-05 | 236 | 58 | 6 | GO:1903555 | |
| GeneOntologyBiologicalProcess | negative regulation of interleukin-10 production | 5.24e-05 | 26 | 58 | 3 | GO:0032693 | |
| GeneOntologyBiologicalProcess | tumor necrosis factor production | 5.31e-05 | 237 | 58 | 6 | GO:0032640 | |
| GeneOntologyBiologicalProcess | tumor necrosis factor superfamily cytokine production | 6.10e-05 | 243 | 58 | 6 | GO:0071706 | |
| GeneOntologyBiologicalProcess | regulation of locomotion | ADGRG3 DRD3 CEACAM5 ANGPT1 CSF1R MYLK FN1 SYNE2 BAG4 MAP3K7 PLXNA1 CEACAM1 TBX5 | 6.33e-05 | 1327 | 58 | 13 | GO:0040012 |
| GeneOntologyBiologicalProcess | regulation of immune effector process | 7.15e-05 | 497 | 58 | 8 | GO:0002697 | |
| GeneOntologyBiologicalProcess | regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway | 7.73e-05 | 5 | 58 | 2 | GO:1903381 | |
| GeneOntologyBiologicalProcess | negative regulation of neutrophil apoptotic process | 7.73e-05 | 5 | 58 | 2 | GO:0033030 | |
| GeneOntologyBiologicalProcess | cytotoxic T cell degranulation | 7.73e-05 | 5 | 58 | 2 | GO:0043316 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | FCGR2C DRD3 SETX ANGPT1 RESF1 FN1 FCGR2A FCGR2B BAG4 TOGARAM1 DDHD2 PLXNA1 TBX5 | 8.50e-05 | 1366 | 58 | 13 | GO:0051130 |
| GeneOntologyBiologicalProcess | negative regulation of regulated secretory pathway | 9.88e-05 | 32 | 58 | 3 | GO:1903306 | |
| GeneOntologyBiologicalProcess | regulation of cell migration | ADGRG3 CEACAM5 ANGPT1 CSF1R MYLK FN1 SYNE2 BAG4 MAP3K7 PLXNA1 CEACAM1 TBX5 | 1.14e-04 | 1211 | 58 | 12 | GO:0030334 |
| GeneOntologyBiologicalProcess | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | 1.16e-04 | 6 | 58 | 2 | GO:0036483 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 1.19e-04 | 34 | 58 | 3 | GO:0043116 | |
| GeneOntologyBiologicalProcess | immune effector process | CD84 FCGR2C CEACAM5 ANGPT1 FCGR2A FCGR2B IL21R CR1 MAP3K7 CEACAM1 | 1.26e-04 | 859 | 58 | 10 | GO:0002252 |
| GeneOntologyBiologicalProcess | neutrophil homeostasis | 1.30e-04 | 35 | 58 | 3 | GO:0001780 | |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | CD84 DACT1 CEACAM5 ANGPT1 CSF1R FCGR2A FCGR2B ZNF618 DAPK1 TNFRSF10A CR1 MAP3K7 CEACAM1 | 1.35e-04 | 1430 | 58 | 13 | GO:0044093 |
| GeneOntologyBiologicalProcess | Fc receptor-mediated immune complex endocytosis | 1.62e-04 | 7 | 58 | 2 | GO:0160006 | |
| GeneOntologyBiologicalProcess | Fc-gamma receptor signaling pathway | 1.79e-04 | 39 | 58 | 3 | GO:0038094 | |
| GeneOntologyBiologicalProcess | leukocyte mediated cytotoxicity | 1.80e-04 | 187 | 58 | 5 | GO:0001909 | |
| GeneOntologyBiologicalProcess | cellular component maintenance | 1.88e-04 | 101 | 58 | 4 | GO:0043954 | |
| GeneOntologyBiologicalProcess | regulation of cell motility | ADGRG3 CEACAM5 ANGPT1 CSF1R MYLK FN1 SYNE2 BAG4 MAP3K7 PLXNA1 CEACAM1 TBX5 | 1.93e-04 | 1280 | 58 | 12 | GO:2000145 |
| GeneOntologyBiologicalProcess | regulation of lymphocyte proliferation | 1.97e-04 | 301 | 58 | 6 | GO:0050670 | |
| GeneOntologyBiologicalProcess | negative regulation of multicellular organismal process | CD84 DRD3 CEACAM5 ANGPT1 FN1 FCGR2A FCGR2B UBR5 ZNF423 SIGLEC1 CR1 CEACAM1 TBX5 | 2.00e-04 | 1488 | 58 | 13 | GO:0051241 |
| GeneOntologyBiologicalProcess | regulation of mononuclear cell proliferation | 2.15e-04 | 306 | 58 | 6 | GO:0032944 | |
| GeneOntologyBiologicalProcess | cell killing | 2.19e-04 | 307 | 58 | 6 | GO:0001906 | |
| GeneOntologyBiologicalProcess | negative regulation of B cell activation | 2.24e-04 | 42 | 58 | 3 | GO:0050869 | |
| GeneOntologyBiologicalProcess | acute inflammatory response to antigenic stimulus | 2.24e-04 | 42 | 58 | 3 | GO:0002438 | |
| GeneOntologyBiologicalProcess | negative regulation of exocytosis | 2.75e-04 | 45 | 58 | 3 | GO:0045920 | |
| GeneOntologyBiologicalProcess | regulation of type I hypersensitivity | 2.76e-04 | 9 | 58 | 2 | GO:0001810 | |
| GeneOntologyBiologicalProcess | negative regulation of acute inflammatory response to antigenic stimulus | 2.76e-04 | 9 | 58 | 2 | GO:0002865 | |
| GeneOntologyBiologicalProcess | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 3.03e-04 | 462 | 58 | 7 | GO:0002460 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 3.13e-04 | 47 | 58 | 3 | GO:0001911 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte activation | 3.15e-04 | 211 | 58 | 5 | GO:0051250 | |
| GeneOntologyBiologicalProcess | cell activation | CD84 ADGRG3 KLRF1 CEACAM5 CSF1R FN1 FCGR2A FCGR2B IL21R CR1 MEGF10 CEACAM1 | 3.28e-04 | 1356 | 58 | 12 | GO:0001775 |
| GeneOntologyBiologicalProcess | regulation of leukocyte proliferation | 3.33e-04 | 332 | 58 | 6 | GO:0070663 | |
| GeneOntologyBiologicalProcess | vasculogenesis | 3.40e-04 | 118 | 58 | 4 | GO:0001570 | |
| GeneOntologyBiologicalProcess | type I hypersensitivity | 3.45e-04 | 10 | 58 | 2 | GO:0016068 | |
| GeneOntologyBiologicalProcess | lymphocyte activation | CD84 ADGRG3 KLRF1 CEACAM5 CSF1R FCGR2A FCGR2B IL21R CR1 CEACAM1 | 3.54e-04 | 976 | 58 | 10 | GO:0046649 |
| GeneOntologyBiologicalProcess | negative regulation of immune system process | 3.65e-04 | 631 | 58 | 8 | GO:0002683 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 3.77e-04 | 50 | 58 | 3 | GO:0002834 | |
| GeneOntologyBiologicalProcess | leukocyte activation | CD84 ADGRG3 KLRF1 CEACAM5 CSF1R FN1 FCGR2A FCGR2B IL21R CR1 CEACAM1 | 4.07e-04 | 1186 | 58 | 11 | GO:0045321 |
| GeneOntologyBiologicalProcess | regulation of type IIa hypersensitivity | 4.21e-04 | 11 | 58 | 2 | GO:0001796 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell mediated cytotoxicity | 4.21e-04 | 11 | 58 | 2 | GO:0001915 | |
| GeneOntologyBiologicalProcess | regulation of neutrophil apoptotic process | 4.21e-04 | 11 | 58 | 2 | GO:0033029 | |
| GeneOntologyBiologicalProcess | regulation of type II hypersensitivity | 4.21e-04 | 11 | 58 | 2 | GO:0002892 | |
| GeneOntologyBiologicalProcess | positive regulation of protein kinase activity | 4.40e-04 | 350 | 58 | 6 | GO:0045860 | |
| GeneOntologyBiologicalProcess | regulation of behavior | 4.63e-04 | 128 | 58 | 4 | GO:0050795 | |
| GeneOntologyBiologicalProcess | endocytosis | FCGR2C DRD3 CEACAM5 ANGPT1 FCGR2A FCGR2B SIGLEC1 MEGF10 CEACAM1 | 4.68e-04 | 827 | 58 | 9 | GO:0006897 |
| GeneOntologyBiologicalProcess | regulation of production of molecular mediator of immune response | 4.77e-04 | 231 | 58 | 5 | GO:0002700 | |
| GeneOntologyCellularComponent | external side of plasma membrane | CD84 FCGR2C CEACAM5 FCGR2A FCGR2B IL21R TNFRSF10A CR1 CEACAM1 | 1.39e-05 | 519 | 59 | 9 | GO:0009897 |
| GeneOntologyCellularComponent | side of membrane | CD84 CNTN4 FCGR2C CEACAM5 FCGR2A FCGR2B IL21R MDGA2 TNFRSF10A CR1 CEACAM1 | 2.88e-05 | 875 | 59 | 11 | GO:0098552 |
| GeneOntologyCellularComponent | cell surface | CD84 FCGR2C CEACAM5 CSF1R FCGR2A FCGR2B IL21R ADGRE4P TNFRSF10A CR1 CEACAM1 | 2.42e-04 | 1111 | 59 | 11 | GO:0009986 |
| Domain | IGc2 | CNTN4 CEACAM5 CSF1R HMCN2 MYLK FCGR2A FCGR2B MDGA2 IGSF11 SIGLEC1 CEACAM1 | 1.10e-10 | 235 | 57 | 11 | SM00408 |
| Domain | Ig_sub2 | CNTN4 CEACAM5 CSF1R HMCN2 MYLK FCGR2A FCGR2B MDGA2 IGSF11 SIGLEC1 CEACAM1 | 1.10e-10 | 235 | 57 | 11 | IPR003598 |
| Domain | Ig-like_fold | CD84 CNTN4 CEACAM5 CSF1R HMCN2 MYLK FN1 IGFBP7 FCGR2A FCGR2B IL21R MDGA2 IGSF11 SIGLEC1 PLXNA1 CEACAM1 | 2.00e-10 | 706 | 57 | 16 | IPR013783 |
| Domain | IG | CD84 CNTN4 CEACAM5 CSF1R HMCN2 MYLK IGFBP7 FCGR2A FCGR2B MDGA2 IGSF11 SIGLEC1 CEACAM1 | 3.21e-10 | 421 | 57 | 13 | SM00409 |
| Domain | Ig_sub | CD84 CNTN4 CEACAM5 CSF1R HMCN2 MYLK IGFBP7 FCGR2A FCGR2B MDGA2 IGSF11 SIGLEC1 CEACAM1 | 3.21e-10 | 421 | 57 | 13 | IPR003599 |
| Domain | - | CD84 CNTN4 CEACAM5 CSF1R MYLK FN1 IGFBP7 FCGR2A FCGR2B IL21R MDGA2 IGSF11 SIGLEC1 PLXNA1 CEACAM1 | 8.46e-10 | 663 | 57 | 15 | 2.60.40.10 |
| Domain | IG_LIKE | CD84 CNTN4 CEACAM5 CSF1R HMCN2 MYLK IGFBP7 FCGR2A FCGR2B MDGA2 IGSF11 SIGLEC1 CEACAM1 | 2.08e-09 | 491 | 57 | 13 | PS50835 |
| Domain | Ig-like_dom | CD84 CNTN4 CEACAM5 CSF1R HMCN2 MYLK IGFBP7 FCGR2A FCGR2B MDGA2 IGSF11 SIGLEC1 CEACAM1 | 2.79e-09 | 503 | 57 | 13 | IPR007110 |
| Domain | Ig_I-set | CNTN4 CEACAM5 HMCN2 MYLK IGFBP7 MDGA2 IGSF11 SIGLEC1 CEACAM1 | 5.70e-09 | 190 | 57 | 9 | IPR013098 |
| Domain | I-set | CNTN4 CEACAM5 HMCN2 MYLK IGFBP7 MDGA2 IGSF11 SIGLEC1 CEACAM1 | 5.70e-09 | 190 | 57 | 9 | PF07679 |
| Domain | ig | 1.07e-07 | 190 | 57 | 8 | PF00047 | |
| Domain | Immunoglobulin | 1.07e-07 | 190 | 57 | 8 | IPR013151 | |
| Domain | Ig_2 | 2.84e-06 | 73 | 57 | 5 | PF13895 | |
| Domain | ZF_PHD_2 | 2.02e-04 | 95 | 57 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 2.10e-04 | 96 | 57 | 4 | PS01359 | |
| Domain | V-set | 2.43e-04 | 184 | 57 | 5 | PF07686 | |
| Domain | FN3 | 3.49e-04 | 199 | 57 | 5 | PS50853 | |
| Domain | Ig_V-set | 3.49e-04 | 199 | 57 | 5 | IPR013106 | |
| Domain | FN3_dom | 4.37e-04 | 209 | 57 | 5 | IPR003961 | |
| Domain | Znf_FYVE_PHD | 1.05e-03 | 147 | 57 | 4 | IPR011011 | |
| Domain | PHD | 1.56e-03 | 75 | 57 | 3 | PF00628 | |
| Domain | Znf_PHD-finger | 1.81e-03 | 79 | 57 | 3 | IPR019787 | |
| Domain | G_patch | 2.22e-03 | 23 | 57 | 2 | SM00443 | |
| Domain | G_patch_dom | 2.22e-03 | 23 | 57 | 2 | IPR000467 | |
| Domain | G_PATCH | 2.22e-03 | 23 | 57 | 2 | PS50174 | |
| Domain | G-patch | 2.22e-03 | 23 | 57 | 2 | PF01585 | |
| Domain | - | 2.40e-03 | 449 | 57 | 6 | 3.30.40.10 | |
| Domain | FN3 | 2.44e-03 | 185 | 57 | 4 | SM00060 | |
| Domain | PHD | 2.54e-03 | 89 | 57 | 3 | SM00249 | |
| Domain | Znf_RING/FYVE/PHD | 2.68e-03 | 459 | 57 | 6 | IPR013083 | |
| Domain | Znf_PHD | 2.71e-03 | 91 | 57 | 3 | IPR001965 | |
| Domain | S100_CABP | 3.06e-03 | 27 | 57 | 2 | PS00303 | |
| Domain | S_100 | 3.06e-03 | 27 | 57 | 2 | PF01023 | |
| Domain | DEATH | 3.06e-03 | 27 | 57 | 2 | SM00005 | |
| Domain | S100_Ca-bd_sub | 3.29e-03 | 28 | 57 | 2 | IPR013787 | |
| Domain | S100/CaBP-9k_CS | 3.29e-03 | 28 | 57 | 2 | IPR001751 | |
| Domain | hEGF | 3.29e-03 | 28 | 57 | 2 | PF12661 | |
| Domain | S_100 | 3.29e-03 | 28 | 57 | 2 | SM01394 | |
| Domain | EGF_CA | 3.44e-03 | 99 | 57 | 3 | PS01187 | |
| Domain | ASX_HYDROXYL | 3.53e-03 | 100 | 57 | 3 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 4.16e-03 | 106 | 57 | 3 | IPR000152 | |
| Domain | Death | 4.55e-03 | 33 | 57 | 2 | PF00531 | |
| Domain | GPS | 4.82e-03 | 34 | 57 | 2 | SM00303 | |
| Domain | GPS | 5.10e-03 | 35 | 57 | 2 | PF01825 | |
| Domain | GPS | 5.39e-03 | 36 | 57 | 2 | PS50221 | |
| Domain | GPS | 5.69e-03 | 37 | 57 | 2 | IPR000203 | |
| Domain | EGF_3 | 5.73e-03 | 235 | 57 | 4 | PS50026 | |
| Domain | Death_domain | 6.00e-03 | 38 | 57 | 2 | IPR000488 | |
| Domain | DEATH_DOMAIN | 6.00e-03 | 38 | 57 | 2 | PS50017 | |
| Domain | EGF-like_Ca-bd_dom | 6.44e-03 | 124 | 57 | 3 | IPR001881 | |
| Domain | EGF-like_dom | 7.01e-03 | 249 | 57 | 4 | IPR000742 | |
| Domain | EGF_1 | 7.61e-03 | 255 | 57 | 4 | PS00022 | |
| Domain | EGF-like_CS | 8.24e-03 | 261 | 57 | 4 | IPR013032 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 1.02e-02 | 50 | 57 | 2 | PS00650 | |
| Domain | 7tm_2 | 1.02e-02 | 50 | 57 | 2 | PF00002 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 1.50e-05 | 158 | 48 | 6 | MM14812 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 4.77e-05 | 194 | 48 | 6 | M16312 | |
| Pathway | KEGG_LEISHMANIA_INFECTION | 1.03e-04 | 72 | 48 | 4 | M3126 | |
| Pathway | REACTOME_FIBRONECTIN_MATRIX_FORMATION | 1.69e-04 | 6 | 48 | 2 | M26970 | |
| Pubmed | Functional Fcgamma receptor polymorphisms are associated with human allergy. | 4.64e-09 | 3 | 59 | 3 | 24586589 | |
| Pubmed | 4.64e-09 | 3 | 59 | 3 | 26133275 | ||
| Pubmed | 1.85e-08 | 4 | 59 | 3 | 21604261 | ||
| Pubmed | CEACAM1 induces B-cell survival and is essential for protective antiviral antibody production. | 2.24e-08 | 18 | 59 | 4 | 25692415 | |
| Pubmed | 4.63e-08 | 5 | 59 | 3 | 20439936 | ||
| Pubmed | Copy number, linkage disequilibrium and disease association in the FCGR locus. | 4.63e-08 | 5 | 59 | 3 | 20508037 | |
| Pubmed | Ly108: a new member of the mouse CD2 family of cell surface proteins. | 4.63e-08 | 5 | 59 | 3 | 11132158 | |
| Pubmed | 4.63e-08 | 5 | 59 | 3 | 19309690 | ||
| Pubmed | 3.42e-07 | 162 | 59 | 6 | 25826454 | ||
| Pubmed | A Restricted Role for FcγR in the Regulation of Adaptive Immunity. | 3.87e-07 | 9 | 59 | 3 | 29523656 | |
| Pubmed | Influence of the apoA-II gene locus on HDL levels and fatty streak development in mice. | 5.52e-07 | 10 | 59 | 3 | 8422330 | |
| Pubmed | 1.14e-06 | 199 | 59 | 6 | 23382691 | ||
| Pubmed | Establishment of fetomaternal tolerance through glycan-mediated B cell suppression. | 1.31e-06 | 13 | 59 | 3 | 35236989 | |
| Pubmed | 2.22e-06 | 54 | 59 | 4 | 8482578 | ||
| Pubmed | Human FcγRII cytoplasmic domains differentially influence antibody-mediated dengue virus infection. | 2.83e-06 | 2 | 59 | 2 | 23616574 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 19284648 | ||
| Pubmed | FcγRIIb on myeloid cells rather than on B cells protects from collagen-induced arthritis. | 2.83e-06 | 2 | 59 | 2 | 24842758 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 17548594 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 17013985 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 25904149 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 21078890 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 33616086 | ||
| Pubmed | Etanercept prevents TNF-α mediated mandibular bone loss in FcγRIIb-/- lupus model. | 2.83e-06 | 2 | 59 | 2 | 33861790 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 31758072 | ||
| Pubmed | FcgammaRIIb inhibits allergic lung inflammation in a murine model of allergic asthma. | 2.83e-06 | 2 | 59 | 2 | 20179765 | |
| Pubmed | Respiratory syncytial virus persistence in macrophages upregulates Fcgamma receptors expression. | 2.83e-06 | 2 | 59 | 2 | 24509813 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 21477339 | ||
| Pubmed | Therapeutic inhibition of FcγRIIb signaling targets leukemic stem cells in chronic myeloid leukemia. | 2.83e-06 | 2 | 59 | 2 | 32684632 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 11983693 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 34248948 | ||
| Pubmed | Negative regulation of c-kit-mediated cell proliferation by Fc gamma RIIB. | 2.83e-06 | 2 | 59 | 2 | 10201978 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 20083655 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 2531080 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 2138787 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 8069908 | ||
| Pubmed | Genetic control of T-cell proliferative response in mice linked to chromosomes 11 and 15. | 2.83e-06 | 2 | 59 | 2 | 8824160 | |
| Pubmed | Regulation of allograft survival by inhibitory FcγRIIb signaling. | 2.83e-06 | 2 | 59 | 2 | 23150718 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 7664793 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 29597194 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 38087748 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 21357255 | ||
| Pubmed | Selective regulation of autoreactive B cells by FcgammaRIIB. | 2.83e-06 | 2 | 59 | 2 | 19327966 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 12370366 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 24366619 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 26245154 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 12729187 | ||
| Pubmed | Structural heterogeneity and functional domains of murine immunoglobulin G Fc receptors. | 2.83e-06 | 2 | 59 | 2 | 2946078 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 16476768 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 18182380 | ||
| Pubmed | Bacterial protein domains with a novel Ig-like fold target human CEACAM receptors. | 2.83e-06 | 2 | 59 | 2 | 33522633 | |
| Pubmed | Differences in endocytosis mediated by FcγRIIA and FcγRIIB2. | 2.83e-06 | 2 | 59 | 2 | 21945020 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 16925577 | ||
| Pubmed | FcgRIII Deficiency and FcgRIIb Defeciency Promote Renal Injury in Diabetic Mice. | 2.83e-06 | 2 | 59 | 2 | 31534958 | |
| Pubmed | FcγRIIb on liver sinusoidal endothelium clears small immune complexes. | 2.83e-06 | 2 | 59 | 2 | 23053513 | |
| Pubmed | A complementary DNA clone for a macrophage-lymphocyte Fc receptor. | 2.83e-06 | 2 | 59 | 2 | 3024012 | |
| Pubmed | Human rhinovirus type 2-antibody complexes enter and infect cells via Fc-gamma receptor IIB1. | 2.83e-06 | 2 | 59 | 2 | 14990693 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 10704470 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 27207525 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 3161943 | ||
| Pubmed | Lipopolysaccharide Impedes Bone Repair in FcγRIIB-Deficient Mice. | 2.83e-06 | 2 | 59 | 2 | 38069267 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 10704418 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 37539049 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 19461083 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 29760215 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 23897982 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 16757681 | ||
| Pubmed | Identification of multiple isoforms of the low-affinity human IgG Fc receptor. | 2.83e-06 | 2 | 59 | 2 | 2526077 | |
| Pubmed | Polymorphisms in IgG Fc receptor IIB regulatory regions associated with autoimmune susceptibility. | 2.83e-06 | 2 | 59 | 2 | 10866109 | |
| Pubmed | FcγRIIb attenuates TLR4‑mediated NF‑κB signaling in B cells. | 2.83e-06 | 2 | 59 | 2 | 28849025 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 23053716 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 11698426 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 17713556 | ||
| Pubmed | Fc gamma RIIB regulates nasal and oral tolerance: a role for dendritic cells. | 2.83e-06 | 2 | 59 | 2 | 15843524 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 29190833 | ||
| Pubmed | Divergent intracellular sorting of Fc{gamma}RIIA and Fc{gamma}RIIB2. | 2.83e-06 | 2 | 59 | 2 | 20736173 | |
| Pubmed | FcγRIIB regulation of BCR/TLR-dependent autoreactive B-cell responses. | 2.83e-06 | 2 | 59 | 2 | 20809520 | |
| Pubmed | FcgammaRIIB mediates C-reactive protein inhibition of endothelial NO synthase. | 2.83e-06 | 2 | 59 | 2 | 16269657 | |
| Pubmed | The inhibiting Fc receptor for IgG, FcγRIIB, is a modifier of autoimmune susceptibility. | 2.83e-06 | 2 | 59 | 2 | 21724994 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 18957413 | ||
| Pubmed | Fcgamma receptor-dependent expansion of a hyperactive monocyte subset in lupus-prone mice. | 2.83e-06 | 2 | 59 | 2 | 19644866 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 21969314 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 25267791 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 24869670 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 30610165 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 26210906 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 18156625 | ||
| Pubmed | A regulatory role for Fc gamma receptors (CD16 and CD32) in hematopoiesis. | 2.83e-06 | 2 | 59 | 2 | 10397164 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 29774664 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 1386873 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 1910686 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 37030590 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 38147316 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 20484044 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 24654803 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 19758787 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 9516136 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 6974691 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 18604868 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 20819092 | ||
| Pubmed | Functional Role of FcγRIIB in the Regulation of Mesenchymal Stem Cell Function. | 2.83e-06 | 2 | 59 | 2 | 26941575 | |
| Cytoband | 8p11.23 | 1.06e-04 | 12 | 59 | 2 | 8p11.23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q23 | 2.10e-04 | 226 | 59 | 4 | chr1q23 | |
| Cytoband | 1q23 | 4.04e-04 | 23 | 59 | 2 | 1q23 | |
| Cytoband | 6q15 | 7.37e-04 | 31 | 59 | 2 | 6q15 | |
| GeneFamily | Immunoglobulin like domain containing | 2.12e-09 | 193 | 49 | 9 | 594 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | CD84 FCGR2C CEACAM5 CSF1R FCGR2A FCGR2B IL21R SIGLEC1 TNFRSF10A CR1 CEACAM1 | 6.35e-09 | 394 | 49 | 11 | 471 |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.10e-08 | 161 | 49 | 8 | 593 | |
| GeneFamily | EF-hand domain containing|S100 fused type protein family | 1.50e-04 | 7 | 49 | 2 | 1350 | |
| GeneFamily | G-patch domain containing|Minor histocompatibility antigens | 1.61e-03 | 22 | 49 | 2 | 579 | |
| GeneFamily | PHD finger proteins | 1.86e-03 | 90 | 49 | 3 | 88 | |
| GeneFamily | CD molecules|V-set domain containing|Immunoglobulin like domain containing|Carcinoembryonic antigen related cell adhesion molecule family | 1.91e-03 | 24 | 49 | 2 | 906 | |
| GeneFamily | Fibronectin type III domain containing | 9.30e-03 | 160 | 49 | 3 | 555 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 9.79e-03 | 163 | 49 | 3 | 590 | |
| Coexpression | GSE4590_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_DN | 2.79e-05 | 157 | 59 | 5 | M6871 | |
| Coexpression | ROZANOV_MMP14_TARGETS_UP | 3.03e-05 | 267 | 59 | 6 | M12890 | |
| Coexpression | LIAN_LIPA_TARGETS_6M | 3.55e-05 | 82 | 59 | 4 | M4345 | |
| Coexpression | NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP | 3.73e-05 | 83 | 59 | 4 | M17951 | |
| Coexpression | TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN | 4.21e-05 | 30 | 59 | 3 | M3210 | |
| Coexpression | OUYANG_PROSTATE_CANCER_MARKERS | 6.74e-05 | 35 | 59 | 3 | MM757 | |
| Coexpression | LIAN_LIPA_TARGETS_6M | 6.86e-05 | 97 | 59 | 4 | MM1016 | |
| Coexpression | GSE29618_BCELL_VS_PDC_DAY7_FLU_VACCINE_UP | 7.64e-05 | 194 | 59 | 5 | M4958 | |
| Coexpression | GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_48H_ACT_CD4_TCELL_UP | 7.82e-05 | 195 | 59 | 5 | M4228 | |
| Coexpression | GSE29618_BCELL_VS_PDC_UP | 8.02e-05 | 196 | 59 | 5 | M4940 | |
| Coexpression | GSE24634_TREG_VS_TCONV_POST_DAY5_IL4_CONVERSION_DN | 8.41e-05 | 198 | 59 | 5 | M4603 | |
| Coexpression | GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_UP | 8.61e-05 | 199 | 59 | 5 | M4460 | |
| Coexpression | GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_ADULT_UP | 8.82e-05 | 200 | 59 | 5 | M4559 | |
| Coexpression | GSE18281_CORTICAL_THYMOCYTE_VS_WHOLE_CORTEX_THYMUS_DN | 8.82e-05 | 200 | 59 | 5 | M7240 | |
| Coexpression | GSE17721_CPG_VS_GARDIQUIMOD_2H_BMDC_DN | 8.82e-05 | 200 | 59 | 5 | M3882 | |
| Coexpression | NABA_MATRISOME | 8.88e-05 | 1026 | 59 | 10 | M5889 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_UP | 1.49e-04 | 689 | 59 | 8 | MM1041 | |
| Coexpression | MARTINEZ_TP53_TARGETS_UP | 1.56e-04 | 694 | 59 | 8 | MM1039 | |
| Coexpression | ASTON_MAJOR_DEPRESSIVE_DISORDER_UP | 1.85e-04 | 49 | 59 | 3 | M25 | |
| Coexpression | HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_DN | 2.42e-04 | 740 | 59 | 8 | M41202 | |
| CoexpressionAtlas | Myeloid Cells, Mo.6C+II+.Bl, CD115+ B220- CD43+ Ly6C+ MHCIIint, Blood, avg-4 | 1.33e-06 | 71 | 57 | 5 | GSM605868_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | CNTN4 SETX MYLK ZNF618 ASXL3 ZNF423 KAT6B TMEM26 MAP3K7 MEGF10 TBX5 | 9.46e-06 | 818 | 57 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | Myeloid Cells, DC.II+480lo.PC, F4/80lo MHC II+ CD11c+ CD115+, Peritoneal Cavity, avg-3 | 1.66e-05 | 424 | 57 | 8 | GSM854294_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.75e-05 | 120 | 57 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k1 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II+480int.PC, CD115+ MHC II+ F480lo SiglecF- CD11c+, Peritoneal Cavity, avg-3 | 1.93e-05 | 433 | 57 | 8 | GSM605856_500 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II-480int.PC, CD115+ MHCII- F480int SiglecF- CD11c+, Peritoneal Cavity, avg-3 | 2.06e-05 | 437 | 57 | 8 | GSM605865_500 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II-480hi.PC, CD115+ MHC II- F480hi Siglec F-, Peritoneal Cavity, avg-3 | 2.20e-05 | 441 | 57 | 8 | GSM605862_500 | |
| CoexpressionAtlas | Myeloid Cells, MF.Medl.SLN, CD11b+ CD169+ F4/80+, Lymph Node, avg-2 | 2.63e-05 | 64 | 57 | 4 | GSM854322_100 | |
| CoexpressionAtlas | Myeloid Cells, Mo.6C+II-.Bl, Cd115+ B220- CD43+ Ly6C+ MHCII-, Blood, avg-3 | 3.54e-05 | 69 | 57 | 4 | GSM605872_100 | |
| CoexpressionAtlas | Myeloid Cells, Mo.6C-II+.Bl, CD115+ B220- CD43+ Ly6C- MHCIIhi, Blood, avg-2 | 3.96e-05 | 71 | 57 | 4 | GSM605878_100 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II+480lo.PC, CD115+ MHC II+ F480lo SiglecF- CD11c+, Peritoneal Cavity, avg-3 | 4.19e-05 | 72 | 57 | 4 | GSM605859_100 | |
| CoexpressionAtlas | Myeloid Cells, MF.Lv, CD45+ F4/80+ CD11b+, Liver, avg-2 | 4.19e-05 | 72 | 57 | 4 | GSM854320_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | CSF1R IGFBP7 UBR5 PCLO SYNE2 MDGA2 IGSF11 KAT6B TMEM26 NKRF DOP1A | 5.16e-05 | 983 | 57 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_200 | 5.74e-05 | 78 | 57 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_200_k5 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II+480int.PC, CD115+ MHC II+ F480lo SiglecF- CD11c+, Peritoneal Cavity, avg-3 | 6.34e-05 | 80 | 57 | 4 | GSM605856_100 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II-480int.PC, CD115+ MHCII- F480int SiglecF- CD11c+, Peritoneal Cavity, avg-3 | 6.66e-05 | 81 | 57 | 4 | GSM605865_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+.Lv, CD45+ CD11c+ MHC-II + CD11b high CD103-, Liver, avg-3 | 8.41e-05 | 86 | 57 | 4 | GSM538239_100 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_1000 | 8.47e-05 | 858 | 57 | 10 | gudmap_dev gonad_e11.5_F_GonMes_Sma_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_200 | 9.53e-05 | 171 | 57 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_200 | |
| CoexpressionAtlas | Myeloid Cells, Mo.6C-II-.BM, B220neg CD3neg CD115+ Ly-6C/Glo CD43+, Bone marrow, avg-3 | 1.08e-04 | 409 | 57 | 7 | GSM854332_500 | |
| CoexpressionAtlas | Myeloid Cells, Mo.6C-II+.Bl, CD115+ B220- CD43+ Ly6C- MHCIIhi, Blood, avg-2 | 1.14e-04 | 413 | 57 | 7 | GSM605878_500 | |
| CoexpressionAtlas | Myeloid Cells, GN.Thio.PC, CD11b+ Ly6-G+, Peritoneal Cavity, avg-3 | 1.20e-04 | 416 | 57 | 7 | GSM854309_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_500 | 1.29e-04 | 421 | 57 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_500 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II+480lo.PC, CD115+ MHC II+ F480lo SiglecF- CD11c+, Peritoneal Cavity, avg-3 | 1.39e-04 | 426 | 57 | 7 | GSM605859_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.40e-04 | 98 | 57 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.85e-04 | 197 | 57 | 5 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K2 | |
| CoexpressionAtlas | PP_GMP_top-relative-expression-ranked_2500_k-means-cluster#4 | 2.39e-04 | 327 | 57 | 6 | PP_GMP_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.43e-04 | 328 | 57 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#2_top-relative-expression-ranked_500 | 2.50e-04 | 114 | 57 | 4 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k2_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.71e-04 | 214 | 57 | 5 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000_k4 | |
| CoexpressionAtlas | B cells, B.Pl.AA4+220+.BM, CD138+ AA4.1+ CD43- CD45R+, Bone marrow, avg-3 | 2.81e-04 | 337 | 57 | 6 | GSM777024_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_1000 | 2.87e-04 | 811 | 57 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#5_top-relative-expression-ranked_500 | 2.89e-04 | 217 | 57 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500_k5 | |
| CoexpressionAtlas | Myeloid Cells, MF.Sbcaps.SLN, CD11b+ CD169+ F4/80-, Lymph Node, avg-2 | 3.18e-04 | 345 | 57 | 6 | GSM854324_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | 3.38e-04 | 654 | 57 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000 | 3.43e-04 | 831 | 57 | 9 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | 3.43e-04 | 831 | 57 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 | |
| CoexpressionAtlas | B cells, B.Pl.AA4+220-.BM, CD138+ AA4.1+ CD43- CD45R-, Bone marrow, avg-3 | 3.49e-04 | 51 | 57 | 3 | GSM777027_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_top-relative-expression-ranked_1000 | 3.59e-04 | 836 | 57 | 9 | gudmap_developingKidney_e15.5_Podocyte cells_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#4_top-relative-expression-ranked_200 | 3.69e-04 | 52 | 57 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_200_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.70e-04 | 229 | 57 | 5 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.70e-04 | 229 | 57 | 5 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_1000 | 3.81e-04 | 843 | 57 | 9 | gudmap_developingGonad_e11.5_testes_1000 | |
| CoexpressionAtlas | Myeloid Cells, Mo.6C+II-.LN, F480+ Ly6c+ MHCII lo/+, Lymph Node, avg-3 | 4.88e-04 | 374 | 57 | 6 | GSM605875_500 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.52e-04 | 250 | 57 | 5 | gudmap_developingKidney_e13.5_podocyte cells_1000_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29965_top-relative-expression-ranked_500 | 5.61e-04 | 384 | 57 | 6 | gudmap_developingKidney_e15.5_Endothelial cells_500 | |
| CoexpressionAtlas | Myeloid Cells, MF.Medl.SLN, CD11b+ CD169+ F4/80+, Lymph Node, avg-2 | 6.16e-04 | 391 | 57 | 6 | GSM854322_500 | |
| CoexpressionAtlas | Myeloid Cells, Mo.6C+II-.BM, B220neg CD3neg CD115+ Ly-6C+, Bone marrow, avg-3 | 6.16e-04 | 391 | 57 | 6 | GSM854329_500 | |
| CoexpressionAtlas | B cells, B.Pl.AA4-.BM, CD138+ AA4.1- CD43+, Bone marrow, avg-2 | 6.42e-04 | 394 | 57 | 6 | GSM777030_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1 | 6.48e-04 | 259 | 57 | 5 | Facebase_RNAseq_e8.5_Floor Plate_1000_K1 | |
| CoexpressionAtlas | B cells, proB.FrA.BM, CD19- IgM- CD43+ CD24- AA4.1+ CD45R+ CD117+ IL7R+, Bone marrow, avg-1 | 6.50e-04 | 395 | 57 | 6 | GSM538351_500 | |
| CoexpressionAtlas | Myeloid Cells, MF.RP.Sp, F4/80hi CD11blo CD11c- autofluorescent, Spleen, avg-3 | 7.22e-04 | 403 | 57 | 6 | GSM605853_500 | |
| CoexpressionAtlas | PP_MEG_top-relative-expression-ranked_500_k-means-cluster#4 | 7.44e-04 | 267 | 57 | 5 | PP_MEG_500_K4 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+F4/80lo.Kd, CD45+ CD11c+ I-A/I-E+ CD11b+ F4/80lo, Kidney, avg-3 | 7.50e-04 | 406 | 57 | 6 | GSM854273_500 | |
| CoexpressionAtlas | Myeloid Cells, Mo.6C+II+.Bl, CD115+ B220- CD43+ Ly6C+ MHCIIint, Blood, avg-4 | 7.70e-04 | 408 | 57 | 6 | GSM605868_500 | |
| CoexpressionAtlas | Myeloid Cells, Mo.6C+II-.Bl, Cd115+ B220- CD43+ Ly6C+ MHCII-, Blood, avg-3 | 7.99e-04 | 411 | 57 | 6 | GSM605872_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+.Lv, CD45+ CD11c+ MHC-II + CD11b high CD103-, Liver, avg-3 | 7.99e-04 | 411 | 57 | 6 | GSM538239_500 | |
| CoexpressionAtlas | Myeloid Cells, Mo.6C+II-.LN, F480+ Ly6c+ MHCII lo/+, Lymph Node, avg-3 | 8.12e-04 | 68 | 57 | 3 | GSM605875_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_top-relative-expression-ranked_500 | 8.41e-04 | 415 | 57 | 6 | gudmap_developingKidney_e15.5_Podocyte cells_500 | |
| CoexpressionAtlas | Myeloid Cells, Mo.6C+II-.BM, B220neg CD3neg CD115+ Ly-6C+, Bone marrow, avg-3 | 8.47e-04 | 69 | 57 | 3 | GSM854329_100 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500 | 8.73e-04 | 418 | 57 | 6 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_k-means-cluster#3_top-relative-expression-ranked_1000 | 8.99e-04 | 160 | 57 | 4 | gudmap_developingKidney_e15.5_Podocyte cells_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_500 | 9.17e-04 | 422 | 57 | 6 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29965_top-relative-expression-ranked_1000 | 9.17e-04 | 761 | 57 | 8 | gudmap_developingKidney_e15.5_Endothelial cells_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_top-relative-expression-ranked_1000 | 9.40e-04 | 764 | 57 | 8 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_1000 | |
| CoexpressionAtlas | Myeloid Cells, MF.Lu, CD11chi CD11b- CD103- MHCII- SiglecF+, Lung, avg-3 | 9.51e-04 | 425 | 57 | 6 | GSM538282_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | 1.01e-03 | 773 | 57 | 8 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_ReproVasc_Flk_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.03e-03 | 166 | 57 | 4 | gudmap_dev gonad_e11.5_F_ReproVasc_Flk_k2_1000 | |
| CoexpressionAtlas | Myeloid Cells, Mo.6C-II-.BM, B220neg CD3neg CD115+ Ly-6C/Glo CD43+, Bone marrow, avg-3 | 1.04e-03 | 74 | 57 | 3 | GSM854332_100 | |
| CoexpressionAtlas | B cells, B.Pl.AA4-.BM, CD138+ AA4.1- CD43+, Bone marrow, avg-2 | 1.04e-03 | 74 | 57 | 3 | GSM777030_100 | |
| CoexpressionAtlas | Myeloid Cells, GN.Thio.PC, CD11b+ Ly6-G+, Peritoneal Cavity, avg-3 | 1.04e-03 | 74 | 57 | 3 | GSM854309_100 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | 1.05e-03 | 777 | 57 | 8 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+24+.Lu, MHCII+ CD11c+ CD103- CD11b+ CD24+, Lung, avg-2 | 1.08e-03 | 75 | 57 | 3 | GSM854269_100 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_500 | 1.08e-03 | 436 | 57 | 6 | gudmap_dev gonad_e11.5_F_GonMes_Sma_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | 1.10e-03 | 978 | 57 | 9 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 | |
| CoexpressionAtlas | Myeloid Cells, MF.II-480hi.PC, F4/80hi CD115hi CD11b+ MHC II- CD11c-, Peritoneal Cavity, avg-3 | 1.11e-03 | 438 | 57 | 6 | GSM605850_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_ReproVasc_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 1.12e-03 | 76 | 57 | 3 | gudmap_dev gonad_e11.5_M_ReproVasc_Flk_k4_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | 1.15e-03 | 984 | 57 | 9 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 | |
| CoexpressionAtlas | Myeloid Cells, DC.II+480lo.PC, F4/80lo MHC II+ CD11c+ CD115+, Peritoneal Cavity, avg-3 | 1.17e-03 | 77 | 57 | 3 | GSM854294_100 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_500_k-means-cluster#5 | 1.18e-03 | 172 | 57 | 4 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_500_K5 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000 | 1.18e-03 | 791 | 57 | 8 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000 | |
| CoexpressionAtlas | PP_epoMEP_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.20e-03 | 445 | 57 | 6 | PP_epoMEP_2500_K1 | |
| CoexpressionAtlas | B cells, proB.CLP.BM, CD19- IgM- CD43+ CD24- AA4.1+ CD45R- CD117+ IL7R+, Bone marrow, avg-1 | 1.26e-03 | 79 | 57 | 3 | GSM538343_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | 1.33e-03 | 806 | 57 | 8 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 | |
| CoexpressionAtlas | PP_HSC_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.33e-03 | 454 | 57 | 6 | PP_HSC_2500_K5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.35e-03 | 305 | 57 | 5 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_1000_k2 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+.PolyIC.Lu, CD45 MHCII CD11c CD103 CD11b, Lung, avg-3 | 1.35e-03 | 81 | 57 | 3 | GSM605823_100 | |
| CoexpressionAtlas | Stem Cells, SC.GMP.BM, Lineage- sca1- ckithi CD34+ FcgRhi, Bone marrow, avg-3 | 1.35e-03 | 81 | 57 | 3 | GSM791119_100 | |
| CoexpressionAtlas | Stem Cells, SC.CDP.BM, Sca1- Flt3+ MCSFR+ cKitlo, Bone marrow, avg-3 | 1.40e-03 | 82 | 57 | 3 | GSM791114_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_100 | 1.45e-03 | 83 | 57 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_100 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II-480hi.PC, CD115+ MHC II- F480hi Siglec F-, Peritoneal Cavity, avg-3 | 1.50e-03 | 84 | 57 | 3 | GSM605862_100 | |
| CoexpressionAtlas | B cells, MLP.BM, CD19- IgM- CD43+ CD24- AA4.1+ CD45R- CD117+ IL7R-, Bone marrow, avg-2 | 1.50e-03 | 84 | 57 | 3 | GSM791124_100 | |
| CoexpressionAtlas | geo_heart_top-relative-expression-ranked_500_k-means-cluster#3 | 1.51e-03 | 184 | 57 | 4 | geo_heart_500_K3 | |
| CoexpressionAtlas | Myeloid Cells, MF.II-480hi.PC, F4/80hi CD115hi CD11b+ MHC II- CD11c-, Peritoneal Cavity, avg-3 | 1.60e-03 | 86 | 57 | 3 | GSM605850_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_k-means-cluster#5_top-relative-expression-ranked_500 | 1.60e-03 | 86 | 57 | 3 | gudmap_developingKidney_e15.5_Podocyte cells_500_k5 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 1.60e-03 | 86 | 57 | 3 | GSM777055_100 | |
| CoexpressionAtlas | MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst-Confounder_removed-fold2.0_adjp0.05 | 1.60e-03 | 1245 | 57 | 10 | PCBC_ratio_MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 1.66e-03 | 87 | 57 | 3 | GSM777050_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_1000 | 1.68e-03 | 837 | 57 | 8 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_1000 | 1.84e-03 | 849 | 57 | 8 | gudmap_dev gonad_e11.5_M_GonMes_Sma_1000 | |
| ToppCell | COVID-19-Heart-Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.86e-09 | 189 | 59 | 7 | 2586f4088721c5debec86c2b211b739fd33713eb | |
| ToppCell | LV-08._Macrophage|World / Chamber and Cluster_Paper | 6.30e-09 | 191 | 59 | 7 | e7a0bc46ba9ba772636a583f3387748418e18832 | |
| ToppCell | RV-08._Macrophage|World / Chamber and Cluster_Paper | 6.53e-09 | 192 | 59 | 7 | a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3 | |
| ToppCell | RV-08._Macrophage|RV / Chamber and Cluster_Paper | 6.77e-09 | 193 | 59 | 7 | 12bf98a280f87e4d8f0c6887dfc855da72e47ac1 | |
| ToppCell | COVID-19-Heart-Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 7.02e-09 | 194 | 59 | 7 | f09675cd472200363c458952f00d2e41990800ee | |
| ToppCell | LA-08._Macrophage|World / Chamber and Cluster_Paper | 7.02e-09 | 194 | 59 | 7 | c1805572bcc11b1cd29083329d7b5911489fb758 | |
| ToppCell | LA-08._Macrophage|LA / Chamber and Cluster_Paper | 7.27e-09 | 195 | 59 | 7 | 5e1d5bdb8874091f5a2b1d0a8cc9008165718a97 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.80e-09 | 197 | 59 | 7 | dc56bb758c7c5bd151be66f8f3b7078d085f72c7 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.80e-09 | 197 | 59 | 7 | 2efb5acd56b96e5afd8d72b927f1d53cc443766f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.37e-09 | 199 | 59 | 7 | f965eb89d6d023c83154276b8fded490fd89c100 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.88e-08 | 155 | 59 | 6 | 8fdda4e3657ac56188ae88ed3caf145f4d9d1567 | |
| ToppCell | facs-MAT-Fat-3m-Myeloid-myeloid_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.92e-08 | 163 | 59 | 6 | 5fc836444bc156c8248abee001b0ecbe43f980c9 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-D-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.57e-07 | 183 | 59 | 6 | b12b89debc9dd6396188bc8fe44f54c01c560966 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-D|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.57e-07 | 183 | 59 | 6 | 19cc0009f5332b6e4d4274df123eebbfc80b669a | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D175|Adult / Lineage, Cell type, age group and donor | 1.68e-07 | 185 | 59 | 6 | ab5704b96f1d368911308797d10c7c52766ab134 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.68e-07 | 185 | 59 | 6 | 8207f9eff113eed429e961748c6b17d672a13b33 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.78e-07 | 187 | 59 | 6 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.96e-07 | 190 | 59 | 6 | f573fef3762a30c38cf8fa7f45df0ffbb49dc873 | |
| ToppCell | LV-08._Macrophage|LV / Chamber and Cluster_Paper | 2.08e-07 | 192 | 59 | 6 | 7be12d580aaf2f2f1562203fcad3a44639b8c5a6 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-07 | 193 | 59 | 6 | bd08555f02db8bc903caacae57e80bb91e2556ce | |
| ToppCell | distal-Hematologic-IGSF21+_Dendritic-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.15e-07 | 193 | 59 | 6 | 48ce11778252ae2ef902b30816061b59a3c81695 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM3-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.15e-07 | 193 | 59 | 6 | 93ba635ed69fec9286fe7636b9d258f3d93a22c3 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-07 | 193 | 59 | 6 | 374d0526a071e973c3f43b4564f78f6933bb67ed | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.15e-07 | 193 | 59 | 6 | 6dfdeb793cb5ad6412b6f808b5687a4e74b6ec65 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.22e-07 | 194 | 59 | 6 | 96f16bcd393a0d3f8df479b172b5360ae5a1e663 | |
| ToppCell | 367C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.22e-07 | 194 | 59 | 6 | e3688f4252aae5f849f025d7f453ff4c0c14590b | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM3-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.22e-07 | 194 | 59 | 6 | e455cb469157c044126f9b0b308957d4ee1e608b | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.22e-07 | 194 | 59 | 6 | 48c37251518f96524807b5bd1bbc2820637666ad | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular-Interstitial_macrophage_perivascular_L.1.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.22e-07 | 194 | 59 | 6 | 7b6a34d1f8922b71dcc931421666c1822cec8345 | |
| ToppCell | distal-1-Hematologic-IGSF21+_Dendritic|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.22e-07 | 194 | 59 | 6 | f30c866e5f41ee79bdc6b6e08af962d62b199835 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.22e-07 | 194 | 59 | 6 | 1dce6d4b6ac41f80677e3e4c335a4f383bd76f85 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM3|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.22e-07 | 194 | 59 | 6 | e0cfd18a7ea2251163d61312b9397f8a518c8c51 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.22e-07 | 194 | 59 | 6 | 435406ebe626c702f7d5a99a3d68ee85aa09be95 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.28e-07 | 195 | 59 | 6 | 91a3c439f10c03c5d51d904f512b6a08040edc76 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.28e-07 | 195 | 59 | 6 | 2d485373bfd9bb4bb9236bf0b31d03e132c8018f | |
| ToppCell | COVID-19-Myeloid-Monocyte-derived_macrophages|COVID-19 / group, cell type (main and fine annotations) | 2.28e-07 | 195 | 59 | 6 | c172c5599379c29123340621a36bfb1fc90c2115 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.28e-07 | 195 | 59 | 6 | 34a9462f4e843f3065cc58c17ad71c1b5b836ae1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.35e-07 | 196 | 59 | 6 | 4370473693d2dd4a8c451a4c477eb79baa33ae12 | |
| ToppCell | Mild_COVID-19-Myeloid-MoAM3|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 2.35e-07 | 196 | 59 | 6 | 9faad17aa0b6af5a8ec2dadf7d70b9209d658072 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.43e-07 | 197 | 59 | 6 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | background-Kupffer_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 2.43e-07 | 197 | 59 | 6 | 8b45c7ecc18d188abc8c172d9bf881c95617a46a | |
| ToppCell | nucseq-Immune-Immune_Myeloid-IM|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.43e-07 | 197 | 59 | 6 | 6f41c8f815851968849428ec92c16745bd01a3fb | |
| ToppCell | distal-Hematologic-IGSF21+_Dendritic-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.43e-07 | 197 | 59 | 6 | e77c91f5a1f5a292eda41abf3b1e31180f2c61e1 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-IM-IM|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.43e-07 | 197 | 59 | 6 | 304044ace926943b8eb588f686ecbe5d1689a809 | |
| ToppCell | distal-Hematologic-Interstitial_Macrophage-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.43e-07 | 197 | 59 | 6 | 3b859c3bbb71858b97ce670bd507e67c377b88eb | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.50e-07 | 198 | 59 | 6 | 96883ad8e189a46ed5b7eaafc0543e53682d26ed | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.57e-07 | 199 | 59 | 6 | 9545ac59c8d75f5747dff86cb511a149dc103b31 | |
| ToppCell | Bronchus_Control_(B.)-Immune-TX-MoAM-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 2.57e-07 | 199 | 59 | 6 | fb63885273d906a85fef178d859d20a311eb8a72 | |
| ToppCell | cellseq2-Immune-Immune_Myeloid-IM-IM|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.57e-07 | 199 | 59 | 6 | 372fb9eb90022dc4ac770a75b4e207c33d1d0c43 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.57e-07 | 199 | 59 | 6 | 994e885b8d1874006302a081d13f1ee881d64612 | |
| ToppCell | cellseq2-Immune-Immune_Myeloid-IM|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.57e-07 | 199 | 59 | 6 | dd3bf59cdc18091889cbf6c43f37100ba537843d | |
| ToppCell | cellseq2-Immune-Immune_Myeloid|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.57e-07 | 199 | 59 | 6 | 6c3c9eceea20121ae17ae2462134aa0437f591b3 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CHIT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.57e-07 | 199 | 59 | 6 | 6ce7612ee2ae211eb0f73391e96089ad5431c537 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.65e-07 | 200 | 59 | 6 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.65e-07 | 200 | 59 | 6 | ea039de8bd8b325845ce361f84e600c6dad922ed | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.65e-07 | 200 | 59 | 6 | ad7ae5106141669b353800fece833b3cd5bdccee | |
| ToppCell | Parenchyma_COVID-19-Immune-TX-MoAM-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 2.65e-07 | 200 | 59 | 6 | 33c5615cbedb9e14f4433169babd3a3a51f69b4c | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_other|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.65e-07 | 200 | 59 | 6 | f3dc07a7cc8cf041da8fe610d21af595818cf2d8 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.65e-07 | 200 | 59 | 6 | ad52b38df5c71f28829b04cd0e6b97f0f9f7610a | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.65e-07 | 200 | 59 | 6 | 78d75d381cb2b9a4c9eb7c32a07b014eaee39195 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.65e-07 | 200 | 59 | 6 | c210b98a75ab5d899d7278bc9b577f76a0b3970c | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.65e-07 | 200 | 59 | 6 | a1ae299cf77580a6d1a728ee591888b6d70a19d6 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Macrophage_other|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.65e-07 | 200 | 59 | 6 | 2d2835f97e0ff4f99d384f18e10876575f6bdefd | |
| ToppCell | primary_visual_cortex-Non-neuronal-macrophage-Macrophage-PVM_Mrc1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.23e-07 | 130 | 59 | 5 | 3a0846b74ba34bd0e2a05b4f1f39f3940df93780 | |
| ToppCell | Cerebellum-Hematopoietic-MICROGLIA|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.15e-06 | 139 | 59 | 5 | 75cca1e6c1af289987d5d98455e9c6db81ecdd64 | |
| ToppCell | Cerebellum-Hematopoietic-MICROGLIA-MI1(C1qb)-MICROGLIA_Microglia.C1qb.Mrc1-Tmem119_(Resident_macrophage)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.15e-06 | 139 | 59 | 5 | a077ce50f6d6746d80de35abed5b6dc35b1145b9 | |
| ToppCell | Cerebellum-Hematopoietic-MICROGLIA-MI1(C1qb)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.15e-06 | 139 | 59 | 5 | de34e2f51f6fda638357abb662c111a20b83e70b | |
| ToppCell | Cerebellum-Hematopoietic-MICROGLIA-MI1(C1qb)-MICROGLIA_Microglia.C1qb.Mrc1-Tmem119_(Resident_macrophage)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.15e-06 | 139 | 59 | 5 | 0ae117308bd10d3a7d2688794c69dc5a31cfca5f | |
| ToppCell | Cerebellum-Hematopoietic-MICROGLIA-MI1(C1qb)-MICROGLIA_Microglia.C1qb.Mrc1-Tmem119_(Resident_macrophage)--|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.15e-06 | 139 | 59 | 5 | fac6a3100a277efa1db250e0c576be1a0c901e6d | |
| ToppCell | Cerebellum-Hematopoietic|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.15e-06 | 139 | 59 | 5 | 3913c3828ad4cb5c71380519d0cf5f195e53c51d | |
| ToppCell | facs-Skin-nan-18m-Myeloid-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-06 | 149 | 59 | 5 | 23a1b95c12f2e3708dc003e13fab423e89821f11 | |
| ToppCell | facs-Skin-nan-18m-Myeloid-macrophage|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-06 | 149 | 59 | 5 | c53a3226adc8fd0eaaa842b6a96442287580cbe0 | |
| ToppCell | facs-Skin-nan-18m-Myeloid|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-06 | 149 | 59 | 5 | bb18a18b891af85849b9658d774053f839c9a8e1 | |
| ToppCell | 368C-Lymphocytic-NK_cells|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.67e-06 | 150 | 59 | 5 | 17b3ac5ddc47b9cba0a27b268d63a6e491b2b111 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Hematologic-leukocyte|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-06 | 163 | 59 | 5 | 644c8a8af6a378fced4c70dec9a0de906f8d6e69 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Hematologic-leukocyte|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-06 | 163 | 59 | 5 | aaff80d254131d1f1230bb12b6f43bc061ab5ab3 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Hematologic|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-06 | 163 | 59 | 5 | 8b0f8a2d5b38f3bbff265211a7607acc85fa38b0 | |
| ToppCell | Thalamus-Hematopoietic|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.74e-06 | 166 | 59 | 5 | 76d60ac7ac5d1eaf530f0c741d9c48e0bd58396b | |
| ToppCell | droplet-Heart-nan-24m-Hematologic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-06 | 168 | 59 | 5 | 0d505ddda32141b81173daecad11ca6b091688a9 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-06 | 168 | 59 | 5 | 4ae9e9d93bcd6f4d5815e57fd5afa7a3398a0ec1 | |
| ToppCell | droplet-Heart-nan-24m-Hematologic-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-06 | 168 | 59 | 5 | 0ef2d8dbcccc812dd0d99769048b95cf06faf023 | |
| ToppCell | droplet-Heart-nan-24m-Hematologic-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-06 | 169 | 59 | 5 | 018f82b3271f90e29c29e2d733d5ced6919fc42e | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l4|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.99e-06 | 169 | 59 | 5 | 90c00ab30e582b0e2a2be751e1fae9024cfb9ea6 | |
| ToppCell | Bronchial_Biopsy-Immune-Luminal_Macrophages|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.55e-06 | 175 | 59 | 5 | 1cf99de391552d4f8dbe2ed5b01fc3b8adca61b6 | |
| ToppCell | CF-Myeloid-Neutrophil|Myeloid / Disease state, Lineage and Cell class | 3.55e-06 | 175 | 59 | 5 | 8020c3a34f77e68e8149f87481fb1dddd2ac675e | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.55e-06 | 175 | 59 | 5 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 3.65e-06 | 176 | 59 | 5 | 0923b01137d6f9956ca815b41102c81e82624065 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-CX3CR1+_CD8_Tmem|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.65e-06 | 176 | 59 | 5 | 6b06da40eb97ea2db09f3a769494738b3e5fe3fa | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.75e-06 | 177 | 59 | 5 | 382f0d6bbff01e84b0c7840e74ac865864e6da89 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-06 | 177 | 59 | 5 | 26bad614560609d318bfc9c235a698bca4e1c22c | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-06 | 177 | 59 | 5 | 14fb8d182775dfd0e49aa7e4e12543a85b3b8bd6 | |
| ToppCell | Severe-B_intermediate-10|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.86e-06 | 178 | 59 | 5 | b7374a97c51239782bed658381a02cb1b3d9bf66 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.86e-06 | 178 | 59 | 5 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | Posterior_cortex-Hematopoietic-MICROGLIA|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.96e-06 | 179 | 59 | 5 | 5122fc794509492afde4af8b1b76d51e3070ef05 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.42e-06 | 183 | 59 | 5 | a97f052950429245c3231464271e1ba539863bba | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.42e-06 | 183 | 59 | 5 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 4.42e-06 | 183 | 59 | 5 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.91e-06 | 187 | 59 | 5 | 8e1d6d25db5b5c91a651bb2d66edfcf073a31704 | |
| ToppCell | Fibroblast-A|World / shred on cell class and cell subclass (v4) | 5.04e-06 | 188 | 59 | 5 | 6740bed5fb8f45b6eea17041894b804214c2a4ae | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.04e-06 | 188 | 59 | 5 | cb091912f9b627a78a8793a37df7f1de839f887f | |
| Computational | Genes in the cancer module 128. | 1.41e-05 | 97 | 35 | 5 | MODULE_128 | |
| Computational | Genes in the cancer module 79. | 1.56e-05 | 99 | 35 | 5 | MODULE_79 | |
| Computational | Immune response. | 1.64e-05 | 100 | 35 | 5 | MODULE_170 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 5.26e-04 | 49 | 35 | 3 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Drug | MDL 20,610 | 1.56e-07 | 5 | 58 | 3 | CID000128209 | |
| Drug | TAN-1030A | 3.12e-07 | 6 | 58 | 3 | CID009576886 | |
| Drug | TAN-999 | 5.45e-07 | 7 | 58 | 3 | CID000130283 | |
| Drug | AC1MHTIN | 5.45e-07 | 7 | 58 | 3 | CID003011133 | |
| Drug | Intravenous Immunoglobulin | 8.71e-07 | 8 | 58 | 3 | DB00028 | |
| Drug | AC1NSK5W | 1.30e-06 | 9 | 58 | 3 | CID005311182 | |
| Drug | Palivizumab | 1.86e-06 | 10 | 58 | 3 | DB00110 | |
| Drug | Denny-Jaffe reagent | 1.86e-06 | 10 | 58 | 3 | CID003035979 | |
| Drug | Bevacizumab | 2.55e-06 | 11 | 58 | 3 | DB00112 | |
| Drug | Tositumomab | 2.55e-06 | 11 | 58 | 3 | DB00081 | |
| Drug | Alemtuzumab | 2.55e-06 | 11 | 58 | 3 | DB00087 | |
| Drug | Efalizumab | 2.55e-06 | 11 | 58 | 3 | DB00095 | |
| Drug | Alefacept | 2.55e-06 | 11 | 58 | 3 | DB00092 | |
| Drug | Daclizumab | 3.40e-06 | 12 | 58 | 3 | DB00111 | |
| Drug | Natalizumab | 3.40e-06 | 12 | 58 | 3 | DB00108 | |
| Drug | Rituximab | 3.40e-06 | 12 | 58 | 3 | DB00073 | |
| Drug | Ibritumomab | 3.40e-06 | 12 | 58 | 3 | DB00078 | |
| Drug | Adalimumab | 3.40e-06 | 12 | 58 | 3 | DB00051 | |
| Drug | Gemtuzumab ozogamicin | 3.40e-06 | 12 | 58 | 3 | DB00056 | |
| Drug | Cetuximab | 3.40e-06 | 12 | 58 | 3 | DB00002 | |
| Drug | Trastuzumab | 4.41e-06 | 13 | 58 | 3 | DB00072 | |
| Drug | Basiliximab | 4.41e-06 | 13 | 58 | 3 | DB00074 | |
| Drug | Abciximab | 5.60e-06 | 14 | 58 | 3 | DB00054 | |
| Drug | Etanercept | 5.60e-06 | 14 | 58 | 3 | DB00005 | |
| Drug | Muromonab | 6.98e-06 | 15 | 58 | 3 | DB00075 | |
| Drug | AC1L9LSE | 8.58e-06 | 16 | 58 | 3 | CID000448272 | |
| Drug | Tamoxifen citrate [54965-24-1]; Down 200; 7uM; HL60; HG-U133A | 1.02e-05 | 195 | 58 | 6 | 1366_DN | |
| Drug | 2cgx | 1.25e-05 | 18 | 58 | 3 | CID001548380 | |
| Drug | R13-1 | 1.48e-05 | 19 | 58 | 3 | CID000009666 | |
| Drug | Loestrin | 2.02e-05 | 21 | 58 | 3 | CID000062925 | |
| Drug | AC1Q5JRE | 2.33e-05 | 22 | 58 | 3 | CID000188349 | |
| Drug | Ic 21 | 1.06e-04 | 36 | 58 | 3 | CID000231825 | |
| Drug | AC1L9IGO | 1.06e-04 | 184 | 58 | 5 | CID000445722 | |
| Drug | H5IO6 | 1.06e-04 | 96 | 58 | 4 | CID000025289 | |
| Drug | hydralazine | 1.11e-04 | 186 | 58 | 5 | CID000003637 | |
| Drug | AC1L1K12 | 1.34e-04 | 102 | 58 | 4 | CID000005292 | |
| Drug | 2-Br | 1.34e-04 | 39 | 58 | 3 | CID000007244 | |
| Drug | AC1NS1CY | 1.45e-04 | 40 | 58 | 3 | CID005326941 | |
| Drug | FR 4 | 1.45e-04 | 40 | 58 | 3 | CID005288243 | |
| Drug | 6-Furfurylaminopurine [525-79-1]; Up 200; 18.6uM; MCF7; HT_HG-U133A | 1.46e-04 | 197 | 58 | 5 | 6813_UP | |
| Drug | Carcinine [56897-53-1]; Up 200; 22uM; HL60; HT_HG-U133A | 1.46e-04 | 197 | 58 | 5 | 1305_UP | |
| Drug | Aconitine [302-27-2]; Up 200; 6.2uM; MCF7; HT_HG-U133A | 1.46e-04 | 197 | 58 | 5 | 6797_UP | |
| Drug | Saquinavir mesylate [149845-06-7]; Up 200; 5.2uM; HL60; HT_HG-U133A | 1.49e-04 | 198 | 58 | 5 | 6127_UP | |
| Drug | Bupropion hydrochloride [31677-93-7]; Down 200; 14.4uM; HL60; HG-U133A | 1.49e-04 | 198 | 58 | 5 | 1564_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A | 1.53e-04 | 199 | 58 | 5 | 2566_DN | |
| Drug | S-[2-[3-[[4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] (2R)-2-[4-(2-methylpropyl)phenyl]propanethioate | 1.56e-04 | 41 | 58 | 3 | CID009854504 | |
| Drug | Clidinium bromide [3485-62-9]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 1.56e-04 | 200 | 58 | 5 | 6837_UP | |
| Drug | Artemisinin [63968-64-9]; Up 200; 14.2uM; HL60; HG-U133A | 1.56e-04 | 200 | 58 | 5 | 1714_UP | |
| Drug | AC1Q4P61 | 1.77e-04 | 8 | 58 | 2 | CID000125039 | |
| Drug | tyrphostin 23 | 2.19e-04 | 116 | 58 | 4 | CID000002052 | |
| Drug | AC1L1C1F | 2.66e-04 | 49 | 58 | 3 | CID000001699 | |
| Disease | malaria (implicated_via_orthology) | 5.69e-07 | 9 | 57 | 3 | DOID:12365 (implicated_via_orthology) | |
| Disease | – | 3.76e-06 | 16 | 57 | 3 | 611162 | |
| Disease | Malaria, susceptibility to | 3.76e-06 | 16 | 57 | 3 | cv:C1970028 | |
| Disease | low affinity immunoglobulin gamma Fc region receptor II-a measurement | 4.56e-06 | 17 | 57 | 3 | EFO_0021969 | |
| Disease | Malaria | 7.61e-06 | 20 | 57 | 3 | C0024530 | |
| Disease | malaria (is_implicated_in) | 1.34e-05 | 24 | 57 | 3 | DOID:12365 (is_implicated_in) | |
| Disease | low affinity immunoglobulin gamma Fc region receptor II-b measurement | 1.53e-05 | 25 | 57 | 3 | EFO_0021970 | |
| Disease | gut microbiome measurement, bone density | 1.60e-05 | 78 | 57 | 4 | EFO_0003923, EFO_0007874 | |
| Disease | Parkinson disease | 3.60e-05 | 321 | 57 | 6 | MONDO_0005180 | |
| Disease | crescentic glomerulonephritis (implicated_via_orthology) | 5.47e-05 | 6 | 57 | 2 | DOID:13139 (implicated_via_orthology) | |
| Disease | SYSTEMIC LUPUS ERYTHEMATOSUS | 5.47e-05 | 6 | 57 | 2 | 152700 | |
| Disease | Early Pregnancy Loss | 5.99e-05 | 109 | 57 | 4 | C3830362 | |
| Disease | Miscarriage | 5.99e-05 | 109 | 57 | 4 | C4552766 | |
| Disease | Spontaneous abortion | 5.99e-05 | 109 | 57 | 4 | C0000786 | |
| Disease | Abortion, Tubal | 5.99e-05 | 109 | 57 | 4 | C0000822 | |
| Disease | low affinity immunoglobulin gamma Fc region receptor II-a/b measurement | 7.65e-05 | 7 | 57 | 2 | EFO_0008211 | |
| Disease | lymphoid leukemia (is_implicated_in) | 7.65e-05 | 7 | 57 | 2 | DOID:1037 (is_implicated_in) | |
| Disease | systemic lupus erythematosus (implicated_via_orthology) | 7.98e-05 | 43 | 57 | 3 | DOID:9074 (implicated_via_orthology) | |
| Disease | renal cell carcinoma (is_marker_for) | 1.12e-04 | 128 | 57 | 4 | DOID:4450 (is_marker_for) | |
| Disease | plexin-B2 measurement | 1.31e-04 | 9 | 57 | 2 | EFO_0021867 | |
| Disease | Libman-Sacks Disease | 1.96e-04 | 58 | 57 | 3 | C0242380 | |
| Disease | Systemic lupus erythematosus | 1.99e-04 | 11 | 57 | 2 | cv:C0024141 | |
| Disease | nasopharyngeal neoplasm | 2.11e-04 | 151 | 57 | 4 | EFO_0004252 | |
| Disease | systemic lupus erythematosus (is_implicated_in) | 2.38e-04 | 62 | 57 | 3 | DOID:9074 (is_implicated_in) | |
| Disease | diffuse large B-cell lymphoma (is_implicated_in) | 2.39e-04 | 12 | 57 | 2 | DOID:0050745 (is_implicated_in) | |
| Disease | Lupus Erythematosus, Systemic | 3.56e-04 | 71 | 57 | 3 | C0024141 | |
| Disease | acute graft vs. host disease, donor genotype effect measurement | 3.79e-04 | 15 | 57 | 2 | EFO_0004599, EFO_0007892 | |
| Disease | autoimmune thrombocytopenic purpura (is_implicated_in) | 3.79e-04 | 15 | 57 | 2 | DOID:8924 (is_implicated_in) | |
| Disease | temporal arteritis (is_implicated_in) | 4.32e-04 | 16 | 57 | 2 | DOID:13375 (is_implicated_in) | |
| Disease | serum IgG glycosylation measurement | 5.08e-04 | 523 | 57 | 6 | EFO_0005193 | |
| Disease | Neutropenia | 7.52e-04 | 21 | 57 | 2 | C0027947 | |
| Disease | neurotic disorder | 9.96e-04 | 101 | 57 | 3 | EFO_0004257 | |
| Disease | colon adenocarcinoma (is_implicated_in) | 1.16e-03 | 26 | 57 | 2 | DOID:234 (is_implicated_in) | |
| Disease | memory performance | 1.16e-03 | 409 | 57 | 5 | EFO_0004874 | |
| Disease | urate measurement, bone density | 1.22e-03 | 619 | 57 | 6 | EFO_0003923, EFO_0004531 | |
| Disease | basophil percentage of leukocytes | 1.26e-03 | 243 | 57 | 4 | EFO_0007992 | |
| Disease | Thrombocytopenia | 1.44e-03 | 29 | 57 | 2 | C0040034 | |
| Disease | Carcinoma, Granular Cell | 1.48e-03 | 116 | 57 | 3 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 1.48e-03 | 116 | 57 | 3 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 1.48e-03 | 116 | 57 | 3 | C0205642 | |
| Disease | Carcinoma, Cribriform | 1.48e-03 | 116 | 57 | 3 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 1.48e-03 | 116 | 57 | 3 | C0205641 | |
| Disease | Adenocarcinoma | 1.48e-03 | 116 | 57 | 3 | C0001418 | |
| Disease | Crohn's disease (is_implicated_in) | 1.54e-03 | 30 | 57 | 2 | DOID:8778 (is_implicated_in) | |
| Disease | sugar consumption measurement | 1.64e-03 | 120 | 57 | 3 | EFO_0010158 | |
| Disease | total blood protein measurement | 1.74e-03 | 449 | 57 | 5 | EFO_0004536 | |
| Disease | Acute Myeloid Leukemia, M1 | 1.84e-03 | 125 | 57 | 3 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 1.84e-03 | 125 | 57 | 3 | C1879321 | |
| Disease | hip bone mineral density | 1.88e-03 | 126 | 57 | 3 | EFO_0007702 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CSVHQYESSGTVNND | 316 | O95429 | |
| NGQEAYASSCNSGTS | 1406 | P53355 | |
| NSSACENSGYFQQLE | 206 | Q969T7 | |
| VNNSGSYTCQAHNSD | 291 | P06731 | |
| NSGLYTCQANNSASG | 471 | P06731 | |
| NNDSGEYTCQTGQTS | 96 | P12318 | |
| NDSGEYTCQTGQTSL | 106 | P31994 | |
| PDCYENNSQGTTQSN | 101 | Q86SQ3 | |
| KTQDAGTYQCTATNS | 91 | Q8IWV2 | |
| QSGSDSCNVENLQRY | 56 | Q86Y34 | |
| SGCSQSSAGDNLSYE | 1111 | Q5JWR5 | |
| DGNCRESTTDQYNTN | 51 | Q15389 | |
| SEADTTCSNQYNPSN | 1591 | Q9C0F0 | |
| STVSGTSQNAYGQDS | 51 | Q96L73 | |
| EGDNLQNSTDSRCYG | 116 | Q96LU5 | |
| GNGSSQNSCSYSNLT | 1696 | Q8WYB5 | |
| GKNSEYNSSNCSLSS | 1011 | Q96KG7 | |
| GNTTFSYNSQACERT | 666 | Q6W4X9 | |
| NSSSSNEFSKCDQYG | 406 | Q5D862 | |
| DSGTYSCTASNAQGQ | 481 | Q15746 | |
| CGNSQNILTVSANYS | 2216 | Q5T1H1 | |
| AGNYSCQATNEVGTD | 671 | Q8NDA2 | |
| NDSGEYTCQTGQTSL | 106 | P31995 | |
| GCRNNNSTASSNNAY | 186 | Q9NXR8 | |
| GCQTEADSDTQSPQY | 3566 | Q9Y6V0 | |
| QTEYCVTGNNGSESS | 951 | P56645 | |
| QCQNSSYSYEGNDVS | 766 | Q9UIW2 | |
| PCQYSDEGQSNSATS | 301 | O43318 | |
| ESEFCSSSNTRNGDY | 466 | O94830 | |
| YECHASNSQGQASAS | 246 | Q16270 | |
| TSDDAGTYSCIANNN | 301 | Q7Z553 | |
| TNNATFQNTGTYRCT | 71 | P07333 | |
| FINNTQLSDTGTYQC | 106 | Q5DX21 | |
| QKGSCSNATQYEDTG | 71 | Q9NZS2 | |
| TSEDEQSNYTTNCFG | 741 | Q9NYF0 | |
| QSNYTTNCFGDSESS | 746 | Q9NYF0 | |
| NTDTQFGSTVNYSCN | 1471 | P17927 | |
| VNNSGSYTCHANNSV | 291 | P13688 | |
| SCQETAVTQTYGGNS | 341 | P02751 | |
| GGSTSCNESVRNYEN | 356 | Q9UHN6 | |
| VNITDQSGNYSQECG | 96 | Q9HBE5 | |
| LNYTCGAENSTGASQ | 11 | P35462 | |
| SDTNRQGQQSSSDCY | 776 | P78332 | |
| YCSIQAEGTSQNTSR | 91 | Q6ZUK4 | |
| PQYCQHDNDTTQESS | 4411 | Q8WXH0 | |
| LSTSSNLGSQYQCEN | 281 | Q99593 | |
| TQDSFSIQDGNSQYC | 101 | O15226 | |
| SIQDGNSQYCDSSGF | 106 | O15226 | |
| SQSSFSYPGSNQEAC | 36 | Q9HCM1 | |
| NTTNGQGCTDYVSEV | 1116 | Q7Z333 | |
| YTCTAQNPVSNNSDS | 191 | Q9UIB8 | |
| SGNSNECLQNSGFEY | 51 | Q9UBS8 | |
| TNSSSQNSSEPYTCG | 381 | Q5T7W0 | |
| AYSCQAQDAQGTRSS | 1321 | Q9BZZ2 | |
| NRCTEGVGYTNASNN | 146 | O00220 | |
| SRTSQSYTCNQECDN | 351 | Q8TE23 | |
| SASANSISNGEYPCN | 621 | Q2M1K9 | |
| QQTFGSQTECTSSNG | 791 | Q9Y4F4 | |
| QTNQQKSGSYCGQSE | 261 | Q6XPR3 | |
| RTQSTGNTHDCNQYG | 166 | Q9BUY5 | |
| SSNTNCQNSSGPDAD | 686 | O95071 | |
| GDNSIINCAYSNSAS | 36 | A0A0B4J235 |